Combination Deferasirox and Deferiprone for Severe Iron Overload in Thalassemia

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

August 1, 2015

Study Completion Date

August 1, 2017

Conditions

Thalassemia Major With Severe Transfusional Iron Overload

Interventions

DRUG

Deferasirox and deferiprone

Trial Locations (2)

Children's Hospital of Philadelphia, Philadelphia

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

All Listed Sponsors

collaborator

The Cooley's Anemia Foundation,

OTHER

collaborator

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

lead

Children's Hospital of Philadelphia

OTHER

NCT01709032 - Combination Deferasirox and Deferiprone for Severe Iron Overload in Thalassemia | Biotech Hunter | Biotech Hunter